Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

'Despair' Gene May Link to Mood Disorders

16.11.2009
A gene in the brain that was not previously linked to mood disorders could have a role in biopolar, depression, and schizophrenic conditions.

Pharmacy scientists at the University of Maryland, Baltimore (UMB) have identified antidepressant and anti-anxiety behaviors in tests of mice lacking the gene.

Writing in the journal BMC Neuroscience, Elisabeth Barbier, PhD, postdoctoral fellow at the School of Pharmacy, and Jia Bei Wang, PhD, professor at the School, concluded after running a battery of standard behavioral tests on the mice without the PKCI/HINT1 gene that it may have an important role in mood regulation.

Mice in the study that had what is being called the “despair” gene eventually gave up trying to avoid apparent danger in tests involving swimming or exposure to light—conditions disliked by mice. Mice without the gene kept trying to escape from danger, perhaps abnormally.

“The knockout mice [without the gene] displayed behaviors indicative of changes in mood function, such as increased perseverance and reduced anxiety in open spaces,“ Wang said.

The causes of mood dysfunction, as seen in depressive and bipolar disorders, are still not fully understood. They are believed to be multifactorial and involve heredity, changes in neurotransmitter levels, altered neuroendocrine function, and psychosocial factors.

“We don’t yet know why the deletion of the gene altered the mood status of the mice,” says Wang, a neuroscientist. She says the protein encoded by the gene could be a potential target for development of diagnostic or therapeutic agents that one day might be used for depression, bipolar disorders or schizophrenia. In addition, the knockout mice might be useful as models to study mania. Currently no mania animal model is available.

The researchers discovered the gene while studying the biological receptors in brain cells that respond to opioid drugs. “I thought [such a] receptor can’t be making the entire change in the body. There must be other proteins,” Wang says. The scientists learned that the gene had already been cloned at Columbia University in the City of New York, where medical researchers were studying its possible role in cancer.

Five years ago, Wang searched scientific literature and found no psychological function for the gene, although it is concentrated in the brain. But she was convinced of its importance because the protein for the gene appears in the genome of living things all along the evolutionary spectrum—from bacteria and fungi to worms to humans. “It must be important. It must be essential otherwise why would all these creatures have it?” Wang says.

Also significant, she says, is that other studies have shown that cadavers of people with biopolar and schizophrenia disorders had less protein encoded by the gene in their brains.

By screening large libraries of chemicals, Wang will next search for compounds that may induce changes in the protein of the gene.

Meanwhile, she says, “We are showing the scientific community that this is an important protein that may have something to do with schizophrenia, bipolar [disorders], and depression. But we don’t know how it works. Certainly this opens the door for work on discovering the mechanism, how it changes behavior. This is the first paper to show that this protein is important to these conditions.”

Wang adds that the work may also provide some clue about the pathological basis of schizophrenia and bipolar conditions—or, as she says, “just what happens to those patients.”

According to the February 2008 issue of the journal PLoS Medicine, more prescriptions in 2007 were dispensed for antidepressants—232.7 million nationwide—than for drugs of any other type. U.S. sales of antidepressants totaled $11.9 billion, according to data from IMS Health, Inc.

Steve Berberich | Newswise Science News
Further information:
http://www.umaryland.edu

More articles from Life Sciences:

nachricht Toward a 'smart' patch that automatically delivers insulin when needed
18.01.2017 | American Chemical Society

nachricht 127 at one blow...
18.01.2017 | Stiftung Zoologisches Forschungsmuseum Alexander Koenig, Leibniz-Institut für Biodiversität der Tiere

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

A big nano boost for solar cells

18.01.2017 | Power and Electrical Engineering

Glass's off-kilter harmonies

18.01.2017 | Materials Sciences

Toward a 'smart' patch that automatically delivers insulin when needed

18.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>